Holen Sie sich die Stockscreener-App
25.50
2.12%
0.53
Schlusskurs vom Vortag:
$24.97
Offen:
$25.26
24-Stunden-Volumen:
909.80K
Relative Volume:
0.83
Marktkapitalisierung:
$3.21B
Einnahmen:
$2.25B
Nettoeinkommen (Verlust:
$27.39M
KGV:
151.97
EPS:
0.1678
Netto-Cashflow:
$136.77M
1W Leistung:
-5.20%
1M Leistung:
+4.04%
6M Leistung:
+6.52%
1J Leistung:
+29.44%
1-Tages-Spanne:
$25.19
$25.85
1-Wochen-Bereich:
$24.73
$27.13
52-Wochen-Spanne:
$18.77
$28.82
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA vs VEEV, BTSG, HQY, TEM, TXG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
25.50 | 3.21B | 2.25B | 27.39M | 136.77M | 0.1678 |
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-03 | Eingeleitet | Goldman | Buy |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-12-08 | Eingeleitet | UBS | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-05-03 | Eingeleitet | BofA Securities | Buy |
| 2022-04-28 | Eingeleitet | BTIG Research | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-01-03 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
| 2021-05-24 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-24 | Eingeleitet | Truist | Buy |
| 2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
Privia Health Group Inc (PRVA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PRVA|Privia Health Group Inc|Price:25.500|Chg%:+0.530 - TradingKey
Privia Health stock rebounded from lows to $25.50 as support holds above medium-term averages - Traders Union
3 Reasons to Avoid PRVA and 1 Stock to Buy Instead - Yahoo! Finance Canada
Citi Maintains Privia Health(PRVA.US) With Buy Rating, Raises Target Price to $35 - Moomoo
Privia Health Group Inc (PRVA) Shares Fall 3.6% -- What GF Score of 88 Tells Investors - GuruFocus
(PRVA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Privia Health Group (PRVA) Declines 1.18% as Stock Nears Key Support at $25.55Insider Selling Alerts - dars.gov.et
Top 3 Health Care Stocks That May Implode This Month - Benzinga
Price to book forward of Privia Health Group, Inc. – NASDAQ:PRVA - TradingView
Privia Health Group Insider Sold Shares Worth $588,679, According to a Recent SEC Filing - Moomoo
Privia Health (PRVA) CFO Mountcastle sells 21,275 shares under 10b5-1 plan - Stock Titan
What Does a Privia Health Insider's Sale of Company Shares for $3.6 Million Mean for Investors? - AOL.com
RBC Capital Keeps Their Buy Rating on Privia Health Group (PRVA) - The Globe and Mail
Privia Health Group stock hits 52-week high at $27.71 By Investing.com - Investing.com India
Form 144 Privia Health Group For: 9 July By Investing.com - Investing.com South Africa
Form 4 Privia Health Group Inc For: 9 July By Investing.com - Investing.com Nigeria
Privia Health CFO Mountcastle sells $16,542 in company stock By Investing.com - Investing.com Australia
David Mountcastle sells multiple PRVA shares (PRVA) including 24,734 on 07/02/2026 - Stock Titan
Privia Health CFO Mountcastle sells $16,542 in company stock - Investing.com UK
Privia Health (PRVA) CFO sells 600 shares, keeps over 186K stake - Stock Titan
Privia Health Group stock hits 52-week high at $27.71 - Investing.com
Privia Health Group (PRVA) Holds Steady Amid Sector Shifts – Key Levels in FocusFundamental Weighted - dars.gov.et
RBC Capital Maintains Privia Health(PRVA.US) With Buy Rating, Maintains Target Price $31 - Moomoo
Form 144 Privia Health Group For: 7 July By Investing.com - Investing.com South Africa
Form 4 Privia Health Group Inc For: 7 July By Investing.com - Investing.com Nigeria
Privia Health Group EVP & CFO David Mountcastle sells $680k in shares - Investing.com
Shawn Morris resigns from Privia Health Group board and compliance committee - TradingView
Board member Shawn Morris exits Privia Health (NASDAQ: PRVA) role - Stock Titan
Privia Health Group (PRVA) director reports 112,759-share option exercise and sale - Stock Titan
Privia Health Group (PRVA) CFO sells 24,734 shares in planned trade - Stock Titan
PRVA (NASDAQ: PRVA) Form 144: 600 vested shares; insider sold 24,734 on 07/02/2026 - Stock Titan
Privia Health to report Q2 2026 results on August 6 - scanx.trade
PRVA Q1 2026 Earnings: EPS Misses Estimates by Wide Margin; Shares Edge LowerPerformance Review - dars.gov.et
Privia Health to Report Second Quarter 2026 Results on Thursday, August 6 - The Manila Times
Privia Health sets Aug. 6 earnings call and outlook update - Stock Titan
Press Release: Privia Health to Report Second Quarter 2026 Results on Thursday, August 6 - Moomoo
Privia Health Q1 2026 slides show operational strength, earnings disappoint - Investing.com
Privia Health stock rises 1.79 percent to $27.36 as PriviaHealth shares upbeat Independence Day message - Traders Union
3 Quality Stocks Built For A Pricey Market - Sahm
Form 144 Privia Health Group For: 2 July By Investing.com - Investing.com Nigeria
PRVA (NASDAQ: PRVA) insider sales reported, with restricted stock vesting noted - Stock Titan
Director at Privia Health (PRVA) sells 135,498 shares after option exercise - Stock Titan
Is It Too Late to Buy Privia Health Group Inc (PRVA) After 4.5% Rally? GF Value Says Undervalued - GuruFocus
Privia Health Group stock hits 52-week high at 26.53 USD - Investing.com
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
4.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):